AGL logo

agilon health inc. (AGL)

$115.20

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on AGL

Market cap

$1.93B

EPS

-5.55

P/E ratio

--

Price to sales

0.23

Dividend yield

--

Beta

3.120821

Price on AGL

Previous close

$116.75

Today's open

$111.94

Day's range

$110.02 - $117.11

52 week range

$7.48 - $133.04

Profile about AGL

CEO

Steven J. Sell

Employees

856

Headquarters

Westerville, OH

Exchange

New York Stock Exchange

Shares outstanding

16795774

Issue type

Common Stock

AGL industries and sectors

Healthcare

Healthcare Providers & Services

News on AGL

agilon health, inc. (AGL) Driving Performance at Scale: Technology-Enabled Clinical and Quality Programs Transcript

agilon health, inc. (AGL) Driving Performance at Scale: Technology-Enabled Clinical and Quality Programs Transcript

news source

Seeking Alpha • 20 hours ago

news preview

agilon health: Same Doctors, Higher Risk Scores, Thinner Reserve

agilon health is rated HOLD with a 12-month price target of $98, 14.6% below the $114.81 close. Rising patient risk scores, especially in Ohio and Texas ACOs, drove about half of AGL's 2026 margin upgrade, but sustainability is uncertain. Recent years saw risk-score revenue volatility and the leanest claims reserve in five years, raising questions about future earnings consistency.

news source

Seeking Alpha • Nov 17, 2026

news preview

Fast-paced Momentum Stock Agilon (AGL) Is Still Trading at a Bargain

Agilon (AGL) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

news source

Zacks Investment Research • Nov 16, 2026

news preview

Agilon Health (AGL) Is Up 2.00% in One Week: What You Should Know

Does Agilon Health (AGL) have what it takes to be a top stock pick for momentum investors? Let's find out.

news source

Zacks Investment Research • Nov 16, 2026

news preview

New Strong Buy Stocks for November 16th

HMN, GMRS, AGL, CEPU and ECO have been added to the Zacks Rank #1 (Strong Buy) List on November 16th, 2026.

news source

Zacks Investment Research • Nov 16, 2026

news preview

Best Momentum Stocks to Buy for November 16th

AGL, GMRS and PH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 16th, 2026.

news source

Zacks Investment Research • Nov 16, 2026

news preview

Agilon Health Q3 Earnings Call Highlights

Agilon Health NYSE: AGL raised its full-year 2026 outlook after reporting third-quarter results that exceeded its guidance, driven by higher risk-adjustment revenue, clinical program performance and favorable medical cost development in the first half of the year.

news source

MarketBeat • Nov 5, 2026

news preview

agilon health to Host Virtual Investor Event “Driving Performance At Scale: The agilon Framework” on November 17, 2026

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will host a virtual investor event on Tuesday, November 17, 2026, at 2:00 PM ET. The event will feature Dr. Karthik Rao, chief medical officer; Varun Anand, interim chief technology officer; Heidi Hittner, chief business operations officer; and Dr. Jon Copeland, an agilon physician partner from United Physicians. The.

news source

Business Wire • Nov 5, 2026

news preview

agilon health, inc. (AGL) Q3 2026 Earnings Call Transcript

agilon health, inc. (AGL) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 5, 2026

news preview

agilon health Reports Third Quarter 2026 Results

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2026. “agilon's third quarter results exceeded our expectations, reflecting the disciplined execution and operational progress our team has delivered this year,” said Tim O'Rourke, Chief Executive Officer of agilon health. “Central to that progress is our proximity to physicia.

news source

Business Wire • Nov 4, 2026

news preview

¹ Disclosures

Get started with M1

Invest in agilon health inc.

Open an M1 investment account to buy and sell agilon health inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in AGL on M1